A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia

Saved in:
Bibliographic Details
Main Authors: Döhner, Hartmut (Author) , Müller-Tidow, Carsten (Author) , Lübbert, Michael (Author) , Fiedler, Walter (Author) , Krämer, Alwin (Author) , Westermann, Jörg (Author) , Bug, Gesine (Author) , Schlenk, Richard Friedrich (Author) , Krug, Utz (Author) , Goeldner, Rainer-Georg (Author) , Hilbert, James (Author) , Taube, Tillmann (Author) , Ottmann, Oliver G. (Author)
Format: Article (Journal) Editorial
Language:English
Published: May 2019
In: British journal of haematology
Year: 2019, Volume: 185, Issue: 3, Pages: 583-587
ISSN:1365-2141
DOI:10.1111/bjh.15563
Online Access:Verlag, Volltext: https://doi.org/10.1111/bjh.15563
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15563
Get full text
Author Notes:Hartmut Döhner, Carsten Müller‐Tidow, Michael Lübbert, Walter Fiedler, Alwin Krämer, Jörg Westermann, Gesine Bug, Richard F. Schlenk, Utz Krug, Rainer-Georg Goeldner, James Hilbert, Tillmann Taube, Oliver G. Ottmann
Description
Item Description:Veröffentlicht: 19 November 2018
Gesehen am 04.04.2019
Physical Description:Online Resource
ISSN:1365-2141
DOI:10.1111/bjh.15563